FDA Recalls Finder

FDA Approves New Drug for Rheumatoid Arthritis
11 January 2010, 1:09 pm

The U.S. Food and Drug Administration approved Actemra (tocilizumab) on Friday to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis.

Source: Food and Drug Administration--Press Releases